Evidence map›Paper›PMID 42658833›Full record

ArticlePLoS medicine2026

Enabling equitable open access to commercially funded research publications.

Anja Schmidt, Christopher C Winchester, Catherine Skobe, Diane R Stothard, Eric Topol

Abstract read
In one paragraph

Article in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anja SchmidtTakeda Development Center Americas, Inc., Cambridge, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-2304-8774
Christopher C WinchesterOxford PharmaGenesis, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-3267-3990
Catherine SkobePfizer, New York, New York, United States of America.ORCID https://orcid.org/0000-0002-5220-2566
Diane R StothardEli Lilly and Company, Indianapolis, Indiana, United States of America.ORCID https://orcid.org/0009-0009-3524-6872
Eric TopolScripps Research, La Jolla, California, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmaceutical companies fund much biomedical research, yet many journals restrict open access publishing options for peer-reviewed articles reporting commercially funded research. Expanded publishing options, such as funder-neutral publishing policies, will help address this inequity.

Indexed as

Access to InformationBiomedical ResearchDrug IndustryOpen Access PublishingPeriodicals as TopicPublishingResearch Support as TopicHumansPeer Review, Research

Identifiers

PMID42658833
PMCPMC13521387

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.